GOP	25–39 years	40–59 years	60–79 years	> 80 years	χ2	df	p	V
Total screenings					49,935	3	< 0.001	0.061
Before COVID-19	1,149,367	2,864,384	2,658,900	777,489
During COVID-19	1,096,952	2,356,907	2,007,544	456,670
Change (%)	– 4.56%	– 17.72%	– 24.50%	– 41.26%
General female cancer screening					8808	3	< 0.001	0.036
Before COVID-19	1,149,367	1,350,438	814,114	178,503
During COVID-19	1,096,952	1,231,165	699,064	120,657
Change (%)	– 4.56%	– 8.83%	– 14.13%	– 32.41%
General health checkup					6270	2	< 0.001	0.051
Before COVID-19		646,276	630,480	298,102
During COVID-19		385,588	324,562	132,838
Change (%)		– 40.34%	– 48.52%	– 55.44%
Colorectal cancer screening stool testa					1465	2	< 0.001	0.049
Before COVID-19		110,355	198,460	55,537
During COVID-19		65,387	142,682	31,974
Change (%)		– 40.75%	– 28.11%	– 42.43%
Colorectal cancer screening consultationa					4001	2	< 0.001	0.073
Before COVID-19		111,979	192,864	53,973
During COVID-19		146,618	190,884	48,252
Change (%)		+ 30.93%	– 1.03%	– 10.60%
Colonoscopy					505	1	< 0.001	0.080
Before COVID-19			40,341	4707
During COVID-19			32,481	2060
Change (%)			– 19.48%	– 56.24%
Skin cancer screening					1629	2	< 0.001	0.030
Before COVID-19		450,060	440,908	186,667
During COVID-19		347,037	322,823	120,889
Change (%)		– 22.89%	– 26.78%	– 35.24%
Mammography screeninga					302	1	< 0.001	0.017
Before COVID-19		195,276	341,734
During COVID-19		181,112	295,048
Change (%)		– 7.25%	– 13.66%

^aData from patients ≥ 55 years